We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+1.02%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.06B
AUM Growth
-$1.38M
Cap. Flow
+$20.5M
Cap. Flow %
1.94%
Top 10 Hldgs %
7.1%
Holding
774
New
159
Increased
222
Reduced
220
Closed
120

Top Buys

Rank Stock Value
1
TXG icon
10x Genomics
TXG
+$5.67M
2
SOFI icon
SoFi Technologies
SOFI
+$5.22M
3
TRU icon
TransUnion
TRU
+$4.01M
4
EXPE icon
Expedia Group
EXPE
+$3.93M
5
CNMD icon
CONMED
CNMD
+$3.78M

Top Sells

Rank Stock Value
1
RACE icon
Ferrari
RACE
+$7.81M
2
SWK icon
Stanley Black & Decker
SWK
+$5.62M
3
KMX icon
CarMax
KMX
+$4.41M
4
SG icon
Sweetgreen
SG
+$4.23M
5
MU icon
Micron Technology
MU
+$4.08M

Sector Composition

Rank Sector Weight
1 Technology 20.53%
2 Healthcare 19.51%
3 Industrials 14.23%
4 Consumer Discretionary 11.24%
5 Financials 10.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IAS
151
DELISTED
Integral Ad Science
IAS
$2.5M 0.24%
257,667
+199,473
+343% +$1.91M
PLTR icon
152
Palantir
PLTR
$295B
$2.49M 0.24%
+98,300
New +$2.21M
ABT icon
153
Abbott
ABT
$180B
$2.46M 0.23%
+23,700
New +$2.51M
COTY icon
154
Coty
COTY
$2.33B
$2.44M 0.23%
243,772
+153,391
+170% +$1.64M
LMND icon
155
Lemonade
LMND
$4.62B
$2.44M 0.23%
147,778
+54,973
+59% +$917K
GOOS
156
Canada Goose Holdings
GOOS
$868M
$2.43M 0.23%
188,276
+21,211
+13% +$264K
QGEN icon
157
Qiagen
QGEN
$8.53B
$2.42M 0.23%
57,337
-15,656
-21% -$687K
ITCI
158
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$2.41M 0.23%
35,218
-15,714
-31% -$1.09M
FSV icon
159
FirstService
FSV
$6.32B
$2.41M 0.23%
15,801
+11,181
+242% +$1.69M
BBBY
160
Bed Bath & Beyond
BBBY
$473M
$2.41M 0.23%
+202,366
New +$3.59M
ESAB icon
161
ESAB
ESAB
$5.25B
$2.4M 0.23%
25,406
+22
+0.1% +$2.29K
AME icon
162
Ametek
AME
$55.5B
$2.38M 0.22%
14,251
-5,399
-27% -$933K
GBX icon
163
The Greenbrier Companies
GBX
$1.61B
$2.37M 0.22%
47,825
-22
-0% -$1.14K
HPE icon
164
Hewlett Packard
HPE
$63.2B
$2.37M 0.22%
111,794
AGL icon
165
Agilon Health
AGL
$1.64B
$2.35M 0.22%
14,376
-4,454
-24% -$635K
PH icon
166
Parker-Hannifin
PH
$125B
$2.33M 0.22%
4,602
-88
-2% -$47.2K
META icon
167
Meta Platforms (Facebook)
META
$1.51T
$2.32M 0.22%
4,600
-300
-6% -$146K
KLAC icon
168
KLA
KLAC
$275B
$2.31M 0.22%
28,000
-23,000
-45% -$1.7M
ACA icon
169
Arcosa
ACA
$7.12B
$2.29M 0.22%
27,445
+1,716
+7% +$143K
CART icon
170
Maplebear
CART
$9.92B
$2.28M 0.22%
71,058
+57,798
+436% +$1.99M
SEE
171
DELISTED
Sealed Air
SEE
$2.27M 0.22%
65,279
+57,610
+751% +$2.05M
NXT icon
172
Nextpower Inc
NXT
$15.2B
$2.27M 0.21%
48,356
+1,320
+3% +$65.6K
BCRX icon
173
BioCryst Pharmaceuticals
BCRX
$2.37B
$2.27M 0.21%
366,770
-13,753
-4% -$75.9K
USFD icon
174
US Foods
USFD
$21.4B
$2.26M 0.21%
42,577
-18,500
-30% -$973K
DAN icon
175
Dana Inc
DAN
$2.91B
$2.25M 0.21%
185,518
+60,263
+48% +$784K

Similar funds

PDT Partners's Q2 2024 Portfolio in Review

As of Q2 2024, PDT Partners held 774 positions worth $1.06B, down 0.13% from $1.06B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.

PDT Partners's Q2 2024 filing shows 159 new, 222 increased, 220 reduced and 120 closed positions. Its largest new stake was SoFi Technologies: 740,850 shares worth $4.9M. The largest sale was Ferrari, an estimated $7.81M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Industrials.

  • PDT Partners's largest Q2 2024 buy was SoFi Technologies: 740,850 shares worth $4.9M.
  • PDT Partners added most to 10x Genomics in Q2 2024, an estimated $5.67M increase.
  • PDT Partners's biggest Q2 2024 reduction was Ferrari, cutting an estimated $7.81M.
  • PDT Partners fully exited CarMax in Q2 2024, selling an estimated $4.41M.
  • PDT Partners's ten largest holdings make up 7.1% of its $1.06B portfolio in Q2 2024.
  • PDT Partners opened 159 new positions and closed 120 in Q2 2024.
  • PDT Partners's portfolio value fell 0.13% quarter-over-quarter to $1.06B.

Based on PDT Partners's 13F filing for Q2 2024, filed 15 Aug 2024.